scholarly journals Overcoming acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

Cancer ◽  
2020 ◽  
Vol 126 (9) ◽  
pp. 2024-2033 ◽  
Author(s):  
Hongjing Zang ◽  
Guoqing Qian ◽  
Dan Zong ◽  
Songqing Fan ◽  
Taofeek K. Owonikoko ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Histone Deacetylase Inhibitor ◽  
Acquired Resistance ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Deacetylase Inhibitor ◽  
Epidermal Growth ◽  
Receptor Mutant

scholarly journals ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib

Cancer ◽  
2019 ◽  
Vol 126 (6) ◽  
pp. 1339-1350 ◽  
Author(s):  
Yiting Li ◽  
Hongjing Zang ◽  
Guoqing Qian ◽  
Taofeek K. Owonikoko ◽  
Suresh R. Ramalingam ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Acquired Resistance ◽  
Growth Factor Receptor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Epidermal Growth ◽  
Receptor Mutant ◽  
Erk Inhibition
Sign in / Sign up

Export Citation Format

Share Document